Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Recurrence × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 4 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Neoplasm Metastasis 2 Tissue Adhesions 1 Solid Tumor Refractory to Standard Therapy 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Platinum Resistant Ovarian Cancer 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ototoxicity 1 Neoplasms 1 Myoma 1 Myelodysplastic Syndromes 1 Melanoma 1 Lymphopenia 1 Leiomyoma 1 Hearing Loss 1 Fatigue 1 Digestive Tract 1 Castrate-Resistant Prostate Cancer 1 Cachexia 1 COVID-19 1

Interventions

Dexamethasone 46 Cyclophosphamide 28 Lenalidomide 27 pomalidomide 24 Rituximab 23 venetoclax 22 fludarabine 21 Bortezomib 20 Paclitaxel 18 Gemcitabine 18 carfilzomib 16 Carboplatin 15 pembrolizumab 14 Cisplatin 14 daratumumab 13 Docetaxel 12 Calcium Dobesilate 12 Cytarabine 11 Azacitidine 11 obinutuzumab 10 Nivolumab 10 Bevacizumab 10 tisagenlecleucel 9 ibrutinib 9 durvalumab 8 blinatumomab 8 Injections 8 Cetuximab 8 zanubrutinib 7 selinexor 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00925548 2014-07-24

STRIDE

EMD Serono

Phase 3 Terminated

16 enrolled 6 charts

Breast Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡